2011-0839

S2011-08392021000400206

10.11144/javeriana.umed62-4.derc

Colombia

00 12 2021

62 4 206 223

2012 337 6096 6096

816-21

2000

2005

2020 50 1-2 1-2

183-98

2002

2017

2018

70-1

2018

10.

2014 12

11.

2015 6

363-72

12.

2018

13.

2012 338

971-5

14.

2015 30

2014-21

15.

National Institutes of Health Recombinant DNA Advisory Committee

2002 3

3-13

16.

2017 24

1-2

17.

2016 283

1218-31

18.

2014 24

132-41

19.

2016 529

490-5

20.

2017 90

653-9

21.

2015 25

767-8

22.

2016 22

411-9

23.

2018

24.

2016 27

223-39

25.

2015 519

410-1

26.

2015 348

36-8

27.

The National Academies of Sciences Engineering and Medicine 2015

28.

The National Academies of Sciences, Engineering and Medicine-Committee on Human Gene Editing 2017

29.

2017 47

15-23

30.

2015

31.

32.

2019 267

165-8

33.

2019

6-7

34.

2009 23

274-90

35.

1994

36.

2002

37.

2016 16

3-15

38.

2002

39.

2010

40.

2015 33

478-86

41.

2016 351

337-9

42.

2017 101 2 2

167-76

43.

International Bioethics Committee (IBC), UNESCO 2015

44.

European Group of Ethics in Sciences and New Technologies (EGE) 2016

45.

Committee on Bioethics (DH.BIO), Council of Europe

1680

46.

Office of Science and Technology Policy, The White House

2015

47.

Human Fertilisation and Embryology Authority (HFEA)

2016

48.

2015 15

25-9

49.

2018 145

50.

2015 373

5-8

51.

Food and Drug Administration (FDA)

2016

52.

1967 157

633

53.

2009 5

309-29

54.

2017

55.

2020 29

77-94

56.

2018 70 5 5

244-54

57.

2018 18 1 1

1-10

58.

2020 15 1 1

1-17

59.

2020 98 7 7

931-46

60.

2016 47 4 4

178-80

61.

Ministerio de Ciencia, Tecnología e Innovación de Colombia 2020

62.

2016 21

79-110

63.

2020 15 1 1

1-23